Latest BioPharma News and In-Depth Analysis | BioPharma BoardRoom

21 November, 2024 | Thursday

Hyloris Announces Commercial Partnership for Maxigesic® IV in 9 European Countries

Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to addressing unmet medical needs through reinventing existing...

January 24, 2023 | Tuesday | News

Helsinn and Immedica enter exclusive partnership for commercialisation of cancer supportive care products in core European markets

Helsinn Group (“Helsinn”), a fully integrated global biopharma company with a track record of over forty years of commercial execution and a st...

January 24, 2023 | Tuesday | News

10
11
12
13
14
15
16
17
18
19

Partner Content

Maximize Time for Innovation: Strategies for Reducing Non-Core Tasks in the Lab
09 August, 2024
Extractables in single-use systems used in ADC manufacturing
19 June, 2024
Empower the Next Wave of Pharmaceutical Breakthroughs with Molecule GEN's AI-Driven Innovation
13 February, 2024
Unleash the Future of Drug Discovery with Molecule GEN: Your AI Odyssey Begins Here!
03 December, 2024
Three Ways Chromatography Data System Software Drives the Lab of the Future
23 October, 2024

BioPharma BreakThrough's

Editor Picks

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

Gene Editing Breakthroughs

Innovative Drug Discovery

Vaccine Development

Biologics and Therapeutic Antibodies

× Please select an option to participate in the poll.

View poll results More polls

× You have successfully cast your vote.

{{ optionDetail.option }} {{ optionDetail.percentage }}%

More polls

About Us Media Pack Contact Us Privacy Policy

© 2024 Biopharma Boardroom. All Rights Reserved.